{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:36:31Z","timestamp":1777894591576,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017549","name":"Science and Technology Innovation 2025 Major Project of Ningbo","doi-asserted-by":"publisher","award":["2023HMYQ09"],"award-info":[{"award-number":["2023HMYQ09"]}],"id":[{"id":"10.13039\/501100017549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.dld.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:27:11Z","timestamp":1771504031000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological features and prognosis of patients with resectable HAS\/GAED: A multicenter nested case\u2013control study from China"],"prefix":"10.1016","volume":"58","author":[{"given":"Lihu","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengqiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moucheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3172-3898","authenticated-orcid":false,"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.02.004_bib0001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","article-title":"Gastric Cancer, Version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Ajani","year":"2025","journal-title":"J Natl Compr Cancer Netw: JNCCN"},{"key":"10.1016\/j.dld.2026.02.004_bib0002","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.3892\/ol.2016.4337","article-title":"Lauren classification and individualized chemotherapy in gastric cancer","volume":"11","author":"Ma","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.dld.2026.02.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28217","article-title":"Assessment of clinicopathological characteristics and development of an individualized prognostic model for patients with hepatoid adenocarcinoma of the stomach","volume":"4","author":"Lin","year":"2021","journal-title":"JAMA Netw open"},{"key":"10.1016\/j.dld.2026.02.004_bib0004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000543330","article-title":"Gastric adenocarcinoma with enteroblastic differentiation","volume":"92","author":"Ferenczi","year":"2025","journal-title":"Pathobiol: J Immunopathol Mol Cell Biol"},{"key":"10.1016\/j.dld.2026.02.004_bib0005","first-page":"840","article-title":"An AFP-producing gastric carcinoma with features of hepatic differentiation","volume":"56","author":"Ishikura","year":"1985","journal-title":"Case Rep, Cancer"},{"key":"10.1016\/j.dld.2026.02.004_bib0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-11-56","article-title":"Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer","volume":"11","author":"Baek","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2026.02.004_bib0007","doi-asserted-by":"crossref","unstructured":"Murakami T, Yao T, Mitomi H, et al. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2016;19:498-507.","DOI":"10.1007\/s10120-015-0497-9"},{"key":"10.1016\/j.dld.2026.02.004_bib0008","doi-asserted-by":"crossref","unstructured":"Abe D, Akazawa Y, Yatagai N, et al. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression. 2023;483:405-14.","DOI":"10.1007\/s00428-023-03623-5"},{"key":"10.1016\/j.dld.2026.02.004_bib0009","doi-asserted-by":"crossref","unstructured":"Wang Y, Sun L, Li Z, et al. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features. 2019;22:1183-92.","DOI":"10.1007\/s10120-019-00965-5"},{"key":"10.1016\/j.dld.2026.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/PAS.0b013e3181f0a873","article-title":"Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach","volume":"34","author":"Liu","year":"2010","journal-title":"Am, J Surg, Pathol"},{"key":"10.1016\/j.dld.2026.02.004_bib0011","article-title":"Molecular profiling of hepatoid adenocarcinoma and adenocarcinoma with enteroblastic differentiation","volume":"64","author":"Matsumoto","year":"2025","journal-title":"Surg Oncol"},{"key":"10.1016\/j.dld.2026.02.004_bib0012","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 2024;74:229-63.","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.dld.2026.02.004_bib0013","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.62347\/DBFO6813","article-title":"Clinicopathological characteristics and prognostic outcomes of resectable hepatoid adenocarcinoma of the stomach: insights from a multicenter case-control study","volume":"15","author":"Xiang","year":"2025","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.dld.2026.02.004_bib0014","doi-asserted-by":"crossref","unstructured":"Machlowska J, Baj J. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. 2020;21.","DOI":"10.3390\/ijms21114012"},{"key":"10.1016\/j.dld.2026.02.004_bib0015","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.62347\/RRHG4189","article-title":"Gastric adenocarcinoma with intestinal progenitor cell differentiation: a morphologically underdiagnosed and more invasive distinctive type of gastric adenocarcinoma","volume":"14","author":"Ge","year":"2024","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.dld.2026.02.004_bib0016","doi-asserted-by":"crossref","unstructured":"Zhang F, Chen H, Luo D, et al. Lymphovascular or perineural invasion is associated with lymph node metastasis and survival outcomes in patients with gastric cancer. 2023;12:9401-8.","DOI":"10.1002\/cam4.5701"},{"key":"10.1016\/j.dld.2026.02.004_bib0017","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12325-008-0100-4","article-title":"Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer","volume":"25","author":"Ucar","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.dld.2026.02.004_bib0018","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5301\/JBM.5000023","article-title":"Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer","volume":"28","author":"Jiexian","year":"2013","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.dld.2026.02.004_bib0019","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.5301\/jbm.5000167","article-title":"High level of serum AFP is an independent negative prognostic factor in gastric cancer","volume":"30","author":"Chen","year":"2015","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.dld.2026.02.004_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4143\/crt.2008.40.1.16","article-title":"Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas","volume":"40","author":"Park","year":"2008","journal-title":"Cancer res treat"},{"key":"10.1016\/j.dld.2026.02.004_bib0021","doi-asserted-by":"crossref","unstructured":"Huang YQ, Huang ZN, Hong QQ, et al. Development of a staging system for hepatoid adenocarcinoma of the stomach based on multicenter data: a retrospective cohort study. 2025;111:718-27.","DOI":"10.1097\/JS9.0000000000001768"},{"key":"10.1016\/j.dld.2026.02.004_bib0022","doi-asserted-by":"crossref","unstructured":"Maurice MM, Angers S. Mechanistic insights into Wnt-\u03b2-catenin pathway activation and signal transduction. 2025;26:371-88.","DOI":"10.1038\/s41580-024-00823-y"},{"key":"10.1016\/j.dld.2026.02.004_bib0023","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.7150\/ijbs.71449","article-title":"Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach","volume":"18","author":"Jiang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.dld.2026.02.004_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.772636","article-title":"Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.dld.2026.02.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101380","article-title":"Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach","volume":"19","author":"Kang","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.dld.2026.02.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.07.001","article-title":"Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: A national multicenter study","volume":"49","author":"Huang","year":"2023","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.dld.2026.02.004_bib0027","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.dld.2014.08.036","article-title":"Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma","volume":"46","author":"Velut","year":"2014","journal-title":"Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2026.02.004_bib0028","doi-asserted-by":"crossref","unstructured":"Weng Y, Liang W, Ji Y, et al. Key Genes and Prognostic Analysis in HER2+ Breast Cancer. 2021;20:1533033820983298.","DOI":"10.1177\/1533033820983298"},{"key":"10.1016\/j.dld.2026.02.004_bib0029","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3748\/wjg.v18.i19.2402","article-title":"Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis","volume":"18","author":"Dang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2026.02.004_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/annonc\/mdi064","article-title":"Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab","volume":"16","author":"Tanner","year":"2005","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.dld.2026.02.004_bib0031","doi-asserted-by":"crossref","unstructured":"Boku N. HER2-positive gastric cancer. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2014;17:1-12.","DOI":"10.1007\/s10120-013-0252-z"},{"key":"10.1016\/j.dld.2026.02.004_bib0032","first-page":"57","article-title":"HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series","volume":"32","author":"Grabsch","year":"2010","journal-title":"Cell Oncol: Off J Int Soc Cell Oncol"},{"key":"10.1016\/j.dld.2026.02.004_bib0033","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S1470-2045(25)00130-5","article-title":"TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial","volume":"26","author":"Zaanan","year":"2025","journal-title":"Lancet Oncol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826002707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826002707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:26:07Z","timestamp":1777620367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1590865826002707"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.02.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological features and prognosis of patients with resectable HAS\/GAED: A multicenter nested case\u2013control study from China","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}